{"component": "definition", "props": {"groups": [{"size": 249, "snippet": "means a third party to whom LICENSEE grants a sublicense of certain rights granted to LICENSEE under this Agreement.", "samples": [{"hash": "jSwDhWE3jz4", "uri": "/contracts/jSwDhWE3jz4#sublicensee", "label": "License Agreement (Sesen Bio, Inc.)", "score": 33.3504447937, "published": true}, {"hash": "4RfpfBiTPtA", "uri": "/contracts/4RfpfBiTPtA#sublicensee", "label": "License Agreement (Molecular Partners Ag)", "score": 31.3045864105, "published": true}, {"hash": "eI9yZSQCLiN", "uri": "/contracts/eI9yZSQCLiN#sublicensee", "label": "License Agreement (HOOKIPA Pharma Inc.)", "score": 29.2183437347, "published": true}], "snippet_links": [{"key": "a-third-party", "type": "clause", "offset": [6, 19]}, {"key": "rights-granted-to-licensee", "type": "clause", "offset": [68, 94]}, {"key": "this-agreement", "type": "clause", "offset": [101, 115]}], "hash": "35a6b76f7ffe63138195a6730f1f5225", "id": 1}, {"size": 141, "snippet": "has the meaning set forth in Section 2.2.", "samples": [{"hash": "1NP1yx3u3le", "uri": "/contracts/1NP1yx3u3le#sublicensee", "label": "Exclusive License Agreement (Standard Biotools Inc.)", "score": 37.5475692749, "published": true}, {"hash": "fo27vSPdbCO", "uri": "/contracts/fo27vSPdbCO#sublicensee", "label": "License and Collaboration Agreement (Biodexa Pharmaceuticals PLC)", "score": 37.2327156067, "published": true}, {"hash": "aN21jORu9M3", "uri": "/contracts/aN21jORu9M3#sublicensee", "label": "Ip Licence Agreement (Biocryst Pharmaceuticals Inc)", "score": 36.7481193542, "published": true}], "snippet_links": [{"key": "section-22", "type": "clause", "offset": [29, 40]}], "hash": "6f82f1f6fd525bc258916e29d8e28d6e", "id": 2}, {"size": 110, "snippet": "means any person or entity granted a Sublicense.", "samples": [{"hash": "gfUADU5KZqT", "uri": "/contracts/gfUADU5KZqT#sublicensee", "label": "License Agreement (Parabilis Medicines, Inc.)", "score": 37.377822876, "published": true}, {"hash": "8vCCX9CrI05", "uri": "/contracts/8vCCX9CrI05#sublicensee", "label": "License Agreement (Parabilis Medicines, Inc.)", "score": 37.2491455078, "published": true}, {"hash": "2yQtp0vWQW5", "uri": "/contracts/2yQtp0vWQW5#sublicensee", "label": "License Agreement (Evogene Ltd.)", "score": 37.2299804688, "published": true}], "snippet_links": [{"key": "person-or-entity", "type": "definition", "offset": [10, 26]}], "hash": "c20c5eb48916f2f9fbb290c7a758254c", "id": 3}, {"size": 88, "snippet": "means any Person, other than a Party or an Affiliate of a Party, to whom a Party (or a downstream Sublicensee of a Party) grants a sublicense of the licenses granted to such Party under this Agreement. Notwithstanding the foregoing, a Third Party Out-Licensee shall not be deemed a Sublicensee.", "samples": [{"hash": "2sDyzVnaJQG", "uri": "/contracts/2sDyzVnaJQG#sublicensee", "label": "Collaboration and License Agreement (Odyssey Therapeutics, Inc.)", "score": 37.2902107239, "published": true}, {"hash": "ePTlG1r6D3N", "uri": "/contracts/ePTlG1r6D3N#sublicensee", "label": "Collaboration and License Agreement (Odyssey Therapeutics, Inc.)", "score": 37.0985641479, "published": true}, {"hash": "42jemUzzxtM", "uri": "/contracts/42jemUzzxtM#sublicensee", "label": "Collaboration and License Agreement (Odyssey Therapeutics, Inc.)", "score": 36.0444908142, "published": true}], "snippet_links": [{"key": "any-person", "type": "definition", "offset": [6, 16]}, {"key": "a-party", "type": "clause", "offset": [29, 36]}, {"key": "affiliate-of", "type": "definition", "offset": [43, 55]}, {"key": "granted-to", "type": "clause", "offset": [158, 168]}, {"key": "such-party", "type": "clause", "offset": [169, 179]}, {"key": "this-agreement", "type": "clause", "offset": [186, 200]}, {"key": "notwithstanding-the-foregoing", "type": "clause", "offset": [202, 231]}, {"key": "a-third-party", "type": "clause", "offset": [233, 246]}, {"key": "licensee-shall", "type": "clause", "offset": [251, 265]}], "hash": "e1228d1e3fd91540c7b56078496a2b93", "id": 4}, {"size": 73, "snippet": "means any third party to whom Licensee confers the right to make, use and sell Licensed Product and/or Licensed Processes.", "samples": [{"hash": "1X6Mhx57jFf", "uri": "/contracts/1X6Mhx57jFf#sublicensee", "label": "Standard Exclusive License Agreement", "score": 31.3408622742, "published": true}, {"hash": "aI5MODdZPHV", "uri": "/contracts/aI5MODdZPHV#sublicensee", "label": "Standard Exclusive License Agreement (ViewRay, Inc.)", "score": 27.7351131439, "published": true}, {"hash": "6zToQCHbvk0", "uri": "/contracts/6zToQCHbvk0#sublicensee", "label": "Standard Exclusive License Agreement (ViewRay, Inc.)", "score": 26.954826355, "published": true}], "snippet_links": [{"key": "third-party", "type": "definition", "offset": [10, 21]}, {"key": "right-to-make", "type": "clause", "offset": [51, 64]}, {"key": "licensed-product", "type": "definition", "offset": [79, 95]}, {"key": "licensed-processes", "type": "definition", "offset": [103, 121]}], "hash": "feeef60ed57c85abb8fbd90cf79f5ade", "id": 5}, {"size": 69, "snippet": "means a third party with whom LICENSEE enters into a Sublicense.", "samples": [{"hash": "dbxm7acq7XM", "uri": "/contracts/dbxm7acq7XM#sublicensee", "label": "License Agreement (Lexeo Therapeutics, Inc.)", "score": 37.2409324646, "published": true}, {"hash": "hroNBFGIH1A", "uri": "/contracts/hroNBFGIH1A#sublicensee", "label": "License Agreement (Allovir, Inc.)", "score": 35.937713623, "published": true}, {"hash": "1v6DfNYfxuF", "uri": "/contracts/1v6DfNYfxuF#sublicensee", "label": "License Agreement (Oncternal Therapeutics, Inc.)", "score": 35.6009597778, "published": true}], "snippet_links": [{"key": "a-third-party", "type": "clause", "offset": [6, 19]}], "hash": "a0911270e93738dbdfcba7f6d73195e8", "id": 6}, {"size": 67, "snippet": "means any permitted sublicensee of the rights granted Company under this Agreement, as further described in Section 2.2.", "samples": [{"hash": "kQkzTRqZwWw", "uri": "/contracts/kQkzTRqZwWw#sublicensee", "label": "Exclusive License Agreement (Tonix Pharmaceuticals Holding Corp.)", "score": 37.1916503906, "published": true}, {"hash": "64maYRM4HrB", "uri": "/contracts/64maYRM4HrB#sublicensee", "label": "Exclusive License Agreement (Generation Bio Co.)", "score": 31.4339485168, "published": true}, {"hash": "1NiFlJpt56Y", "uri": "/contracts/1NiFlJpt56Y#sublicensee", "label": "Exclusive License Agreement (Generation Bio Co.)", "score": 31.2724170685, "published": true}], "snippet_links": [{"key": "permitted-sublicensee", "type": "definition", "offset": [10, 31]}, {"key": "the-rights-granted", "type": "clause", "offset": [35, 53]}, {"key": "this-agreement", "type": "clause", "offset": [68, 82]}, {"key": "section-22", "type": "clause", "offset": [108, 119]}], "hash": "83d901e6db8bd3aeef553e073f55d1c6", "id": 7}, {"size": 67, "snippet": "means a Third Party holding a Sublicense under the Licensed Rights.", "samples": [{"hash": "cNHrmq2denV", "uri": "/contracts/cNHrmq2denV#sublicensee", "label": "Exclusive License Agreement (Icosavax, Inc.)", "score": 34.6153335571, "published": true}, {"hash": "5Wjt9LcyDuW", "uri": "/contracts/5Wjt9LcyDuW#sublicensee", "label": "Non Exclusive License Agreement (Icosavax, Inc.)", "score": 33.2409324646, "published": true}, {"hash": "hjnTMrVICDq", "uri": "/contracts/hjnTMrVICDq#sublicensee", "label": "Exclusive License Agreement (Icosavax, Inc.)", "score": 32.5126609802, "published": true}], "snippet_links": [{"key": "a-third-party", "type": "clause", "offset": [6, 19]}, {"key": "licensed-rights", "type": "clause", "offset": [51, 66]}], "hash": "66bc45fe54a394bcb8a0bf1b1590f177", "id": 8}, {"size": 61, "snippet": "means any person or entity (including any Affiliate or Joint Venture) to which any of the license rights granted to the Licensee hereunder are sublicensed.", "samples": [{"hash": "k0w71nEmwgT", "uri": "/contracts/k0w71nEmwgT#sublicensee", "label": "Exclusive License Agreement (Bioventrix, Inc.)", "score": 37.2080764771, "published": true}, {"hash": "1kUtSlMyXaF", "uri": "/contracts/1kUtSlMyXaF#sublicensee", "label": "Exclusive License Agreement (Aclarion, Inc.)", "score": 33.0136909485, "published": true}, {"hash": "dbntRTQdQJW", "uri": "/contracts/dbntRTQdQJW#sublicensee", "label": "Exclusive License Agreement (OncoCyte Corp)", "score": 32.2114982605, "published": true}], "snippet_links": [{"key": "person-or-entity", "type": "definition", "offset": [10, 26]}, {"key": "joint-venture", "type": "definition", "offset": [55, 68]}, {"key": "granted-to", "type": "clause", "offset": [105, 115]}, {"key": "the-licensee", "type": "definition", "offset": [116, 128]}], "hash": "8b3c9e64099b7dee6e58950888c1568c", "id": 9}, {"size": 52, "snippet": "means any Third Party to whom Licensee (or its Affiliates) grants rights to use some of Licensee's rights under this Agreement.", "samples": [{"hash": "6HHKvoOVF7Q", "uri": "/contracts/6HHKvoOVF7Q#sublicensee", "label": "Exclusive License and Sublicense Agreement (VistaGen Therapeutics, Inc.)", "score": 28.3566055298, "published": true}, {"hash": "7qkNhexbim9", "uri": "/contracts/7qkNhexbim9#sublicensee", "label": "Exclusive License and Sublicense Agreement (VistaGen Therapeutics, Inc.)", "score": 28.3292274475, "published": true}, {"hash": "feqRWRHWFjM", "uri": "/contracts/feqRWRHWFjM#sublicensee", "label": "License Agreement (VistaGen Therapeutics, Inc.)", "score": 23.4996585846, "published": true}], "snippet_links": [{"key": "third-party", "type": "definition", "offset": [10, 21]}, {"key": "rights-to-use", "type": "clause", "offset": [66, 79]}, {"key": "of-licensee", "type": "clause", "offset": [85, 96]}, {"key": "rights-under-this-agreement", "type": "clause", "offset": [99, 126]}], "hash": "93cdbbdf1b63dee8ac680510027aef81", "id": 10}], "next_curs": "ClgSUmoVc35sYXdpbnNpZGVyY29udHJhY3RzcjQLEhpEZWZpbml0aW9uU25pcHBldEdyb3VwX3Y1NiIUc3VibGljZW5zZWUjMDAwMDAwMGEMogECZW4YACAA", "definition": {"title": "Sublicensee", "size": 7166, "snippet": "means a third party to whom LICENSEE grants a sublicense of certain rights granted to LICENSEE under this Agreement.", "id": "sublicensee", "examples": ["Azurity shall provide PolyPid with a copy of each sublicense with each <strong>Sublicensee</strong>, provided that Azurity may redact such copy at its reasonable discretion to remove any terms and information that are not relevant to this Agreement, that are sensitive financial information or the removal of which is required to otherwise comply with Applicable Law.", "Prior to entering into any sublicense, Jupiter shall provide PharmAla with written notice identifying the proposed <strong>Sublicensee</strong>, the rights proposed to be sublicensed, the territory, the field, the proposed scope of activities, and whether such <strong>Sublicensee</strong> or any of its Affiliates is engaged in a Competing Business.", "At Azurity\u2019s request, PolyPid shall join as a party to any Infringement Action or proceeding brought by Azurity or its <strong>Sublicensee</strong> to enforce any Licensed Technology, to the extent PolyPid is a necessary party to such action.", "PolyPid shall have the right to exercise quality control over the use of its Marks by Azurity or any <strong>Sublicensee</strong> to the degree necessary, in the sole opinion of PolyPid, to maintain the validity and enforceability of such Marks and to protect the goodwill associated therewith."], "related": [["sublicensees", "Sublicensees", "<strong>Sublicensees</strong>"], ["licensee", "Licensee", "Licensee"], ["sublicense", "Sublicense", "Sublicense"], ["the-licensee", "the Licensee", "the Licensee"], ["licensor", "Licensor", "Licensor"]], "related_snippets": [], "updated": "2026-07-23T04:28:08+00:00"}, "json": true, "cursor": ""}}